New Class of Biomarkers Predicts Cancer Patient Treatment Response
A new class of blood-based biomarkers could be developed into improved or orthogonal tests for predicting tumor responses to treatment.
Read MorePosted by Melanie Hamilton-Basich | May 26, 2023 | Hematology & Serology, Lung Cancer |
A new class of blood-based biomarkers could be developed into improved or orthogonal tests for predicting tumor responses to treatment.
Read MorePosted by Chris Wolski | May 25, 2023 | Lung Cancer |
OncoHost will give a poster presentation demonstrating the accuracy of its PROphet biomarker model at the upcoming 2023 ASCO Annual Meeting.
Read MorePosted by Melanie Hamilton-Basich | May 12, 2023 | Lung Cancer |
The first lung nodule biopsy procedure using Serpex’s Compass steerable needle guided by Body Vision Medical’s LungVision CT imaging system was used to successfully diagnose a small peripheral nodule in the right lower lobe of the patient’s lung.
Read MorePosted by Melanie Hamilton-Basich | May 4, 2023 | Digital Pathology |
The two companies will provide a fully interoperable solution combining Indica Labs’ HALO AP image management software platform and Lunit’s suite of AI pathology products.
Read MorePosted by Melanie Hamilton-Basich | May 2, 2023 | Colorectal |
EarlySign ColonFlag will now be offered within the navify Algorithm Suite from Roche Diagnostics to improve early detection of colon cancer.
Read More